Helen Sabzevari - 12 May 2022 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role: President and CEO, Director
Signature: /s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Issuer symbol: PGEN
Transactions as of: 12 May 2022
Net transactions value: -$210,928
Form type: 4
Filing time: 16 May 2022, 18:57:35 UTC
Previous filing: 22 Mar 2022
Next filing: 15 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PGEN	Common Stock	Options Exercise		+340,909	+46%		1,075,059	12 May 2022	Direct	F1
transaction	PGEN	Common Stock	Sale	$210,928	-177,968	-17%	$1.19	897,091	13 May 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PGEN	Restricted Stock Units	Options Exercise	$0	-340,909	-100%	$0.000000^*	0	12 May 2022	Common Stock	340,909		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2	This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.
F3	The RSUs were granted on March 18, 2022 and have vested in full.